## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-15T22:59:44.173Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Eye Chart Pro Remote Control"
developer_entity: "Dok LLC"
bundle_id: "com.dok.eyechartproremote"
app_store_id: "448853455"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2024-11-15"
report_date: "2026-05-15"
last_verified: "2026-05-15"
report_version: "2.0.1"
total_reviews: 5
overall_rating: 3
sentiment: "Mixed"
sentiment_score: 50
confidence: "low"
confidence_score: 0.5
review_sample_size: 5
data_age_days: 0
momentum_velocity: "zombie"
intelligence_version: 3
competitor_count: 5
tags: ["medical", "freemium", "mixed sentiment", "mobile app", "app review", "app analysis", "professionals", "clinicians", "using"]
canonical_url: "https://marlvel.ai/intel-report/medical/eye-chart-pro-remote-control"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Eye Chart Pro Remote Control App Audit

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 3 · Sentiment Mixed

> **TL;DR:** Eye Chart Pro Remote Control is a medical app by Dok LLC, rated 3/5 by 5 users, with Mixed user sentiment (50/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Eye Chart Pro Remote Control has Mixed user sentiment with a 3/5 rating from 5 reviews.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3/5 (5 reviews) |
| **User Mood** | Mixed |
| **Category** | Medical |
| **Developer** | Dok LLC |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.5/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Dok LLC
- **Category:** Medical
- **Target Audience:** Eye care professionals and clinicians using Eye Chart Pro iPad software for vision testing.
- **Platforms:** iOS
- **Version Audited:** 2.0.1
- **Audit Date:** 2026-05-15
- **Signal Count:** 8 reviews analyzed
- **Confidence:** Low (0.5/1.0)
- **App Store ID (iOS):** 448853455
- **Bundle ID:** com.dok.eyechartproremote
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-05-15

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Eye Chart Pro Remote Control is a wireless companion app for iPad vision testing software, designed for clinical professionals.
**Why users hire it:** Clinicians hire this tool to manage vision charts remotely during patient exams, reducing the need to touch the iPad screen directly.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Remote Control Functionality:** Turns iPhone or iPod Touch into a wireless controller for Eye Chart Pro iPad applications
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Cross-App Integration:** Provides remote control compatibility across Eye Chart Pro, Eye Chart Premium, and Eye Chart Professional
  * *User Intent:* Users seek enhanced value through premium features.
- **[Basic] Feature Unlocking:** Enables access to additional remote control capabilities when paired with the paid Eye Chart Pro iPad app
  * *User Intent:* Users seek enhanced value through premium features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app maintains a niche utility role for existing iPad software users, evidenced by a 3.0 rating across 5 reviews. Its lack of independent diagnostic features keeps it tethered to the primary iPad software's market share.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free remote control app, Paid-tier gate via Eye Chart Pro iPad app for advanced functionality
- **Analysis:** Freemium model where the remote app is free, but advanced features are gated behind the purchase of the primary iPad medical software.

<!-- section:sentiment -->
## 🟡 User Sentiment (Low Confidence: 5 reviews) {#user-sentiment}
- **Overall Rating:** 3/5
- **Platform Split:** iOS 3.0/5 (5 ratings)
- **Overall Sentiment:** Mixed

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Wireless integration with iPad software creates a specialized clinical workflow
- Freemium model lowers the barrier for existing iPad software users

**Critical Frictions:**
- 3.0 rating on 5 reviews indicates low user satisfaction
- Lack of independent diagnostic functionality limits utility

**Growth Levers:**
- Integration with broader clinical documentation systems could increase switching costs
- Web-based demo deployment could lower entry barriers against new competitors

**Market Threats:**
- Web-integrated screening tools like vision.app threaten legacy mobile-only solutions
- Clinical competitors offering EHR integration provide higher utility for professional users

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The report shifts focus from internal technical connectivity issues to external competitive threats posed by modern, EHR-integrated, and web-based diagnostic tools.

**Overall trend**: Stable
**Compared at**: 2026-05-15

### High-impact changes
- **[Shifted] Competitive Landscape Expansion** (positioning) — The competitive pool shifted from a single nemesis (Pocket Eye Exam) to four distinct clinical and diagnostic competitors (Vocera Edge, EyeQue PDCheck, Color Blindness Test Ishihara, Vision Check).
- **[Improved] Sentiment Classification** (sentiment) — Overall sentiment moved from negative to mixed, with the removal of specific technical complaint themes regarding connectivity and monetization.

### Medium-impact changes
- **[Shifted] SWOT Analysis Reorientation** (swot) — Threats shifted from hardware-level connectivity failures to market-level risks, specifically web-integrated screening tools and EHR integration requirements.
- **[Shifted] Outlook Trend** (positioning) — Outlook trend moved from declining to stable, reflecting the app's transition into a legacy maintenance state.

<!-- section:whats-new -->
## What's New

- **Latest (v2.0.1, 1 years ago):** General bug fixes.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- No notable signals last 3 months

> **Cadence:** 1 total versions · 0 majors in last 6 months · 546 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Eye Chart Pro Remote Control is an established medical app that is free with in-app purchases.
With a 3/5 rating from 5 reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** The app effectively supports the iPad suite's workflow but lacks independent diagnostic value, so the PM should prioritize EHR integration to defend against clinical competitors.
<!-- speakable-end -->

**Best for:** Eye care professionals and clinicians using Eye Chart Pro iPad software for vision testing.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [MEDIUM IMPACT] Audit clinical workflow integration because competitors like Vocera Edge offer EHR connectivity → increase professional stickiness — *Competitor analysis shows EHR integration is a key differentiator for professional medical apps.* _(trade-off: deprioritize Pause the UI refresh sprint — clinical utility has higher retention impact than visual polish.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- EHR system integration (available in Vocera Edge but absent here)
- Personalized vision status reports (available in Color Blindness Test Ishihara but absent here)
- Web-based demo access (available in vision.app but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Stable

The vision testing market is shifting toward web-integrated and EHR-connected tools that offer higher clinical utility. This app remains a legacy peripheral, which will likely lead to gradual user attrition as professionals move to more comprehensive clinical platforms.

- ⚪ The app remains in maintenance mode, which preserves its current utility but leaves it exposed to more feature-rich clinical competitors.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3/5 |
| Total Reviews | 5 |
| Sentiment | Mixed (50/100) |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Eye Chart Pro Remote Control** (this app) | 3/5 | Mixed | Dok LLC |
| [Color Blindness Test Ishihara](https://marlvel.ai/intel-report/medical/color-blindness-test-ishihara) | 3.0/5 | N/A | Rina Katrina |
| [Vocera Edge](https://marlvel.ai/intel-report/medical/vocera-edge) | 5.0/5 | Mixed | PatientSafe Solutions |
| [Vision Check by Optikos Prime](https://marlvel.ai/intel-report/health-fitness/vision-check-by-optikos-prime) | 5.0/5 | N/A | OptikosPrime ApS |
| [EyeQue PDCheck](https://marlvel.ai/intel-report/health-fitness/eyeque-pdcheck) | 3.7/5 | Mixed | EyeQue Corporation |
| [vision.app](https://marlvel.ai/intel-report/health-fitness/vision-app) | N/A/5 | N/A | Capital Certainty SL |

## Company Profile
- **Developer:** Dok LLC
- **Website:** [https://www.eyechartproapp.com/](https://www.eyechartproapp.com/)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/eye-chart-pro-remote-control/id448853455?uo=4)
- **Dev Site:** [Official Website](https://www.eyechartproapp.com/)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*Color Blindness Test Ishihara*](https://marlvel.ai/intel-report/medical/color-blindness-test-ishihara) (Rina Katrina) — 3.0/5 Rating | N/A Sentiment
- [*Vocera Edge*](https://marlvel.ai/intel-report/medical/vocera-edge) (PatientSafe Solutions) — 5.0/5 Rating | Mixed Sentiment
- [*Vision Check by Optikos Prime*](https://marlvel.ai/intel-report/health-fitness/vision-check-by-optikos-prime) (OptikosPrime ApS) — 5.0/5 Rating | N/A Sentiment
- [*EyeQue PDCheck*](https://marlvel.ai/intel-report/health-fitness/eyeque-pdcheck) (EyeQue Corporation) — 3.7/5 Rating | Mixed Sentiment
- [*vision.app*](https://marlvel.ai/intel-report/health-fitness/vision-app) (Capital Certainty SL) — N/A Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*Dario Health*](https://marlvel.ai/intel-report/medical/dario-health) (LabStyle Innovation Ltd) — 4.8/5 Rating | Negative Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 8
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/eye-chart-pro-remote-control)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.